Literature DB >> 21462297

Hand factors as regulators of cardiac morphogenesis and implications for congenital heart defects.

Joshua W Vincentz1, Ralston M Barnes, Anthony B Firulli.   

Abstract

Almost 15 years of careful study have established the related basic Helix-Loop-Helix (bHLH) transcription factors Hand1 and Hand2 as critical for heart development across evolution. Hand factors make broad contributions, revealed through animal models, to the development of multiple cellular lineages that ultimately contribute to the heart. They perform critical roles in ventricular cardiomyocyte growth, differentiation, morphogenesis, and conduction. They are also important for the proper development of the cardiac outflow tract, epicardium, and endocardium. Molecularly, they function both through DNA binding and through protein-protein interactions, which are regulated transcriptionally, posttranscriptionally by microRNAs, and posttranslationally through phosphoregulation. Although direct Hand factor transcriptional targets are progressively being identified, confirmed direct targets of Hand factor transcriptional activity in the heart are limited. Identification of these targets will be critical to model the mechanisms by which Hand factor bHLH interactions affect developmental pathways. Improved understanding of Hand factor-mediated transcriptional cascades will be necessary to determine how Hand factor dysregulation translates to human disease phenotypes. This review summarizes the insight that animal models have provided into the regulation and function of these factors during heart development, in addition to the recent findings that suggest roles for HAND1 and HAND2 in human congenital heart disease.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21462297      PMCID: PMC3119928          DOI: 10.1002/bdra.20796

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  86 in total

1.  Report of the New England Regional Infant Cardiac Program, by Donald C. Fyler, MD, Pediatrics, 1980;65(suppl):375-461.

Authors:  C N Talner
Journal:  Pediatrics       Date:  1998-07       Impact factor: 7.124

Review 2.  Deletion (4)(q33 --> qter): a case report and review of the literature.

Authors:  Z Borochowitz; S A Shalev; I Yehudai; H Bar-el; H Dar; E Tirosh
Journal:  J Child Neurol       Date:  1997-08       Impact factor: 1.987

3.  Cardiac neural crest cells provide new insight into septation of the cardiac outflow tract: aortic sac to ventricular septal closure.

Authors:  K Waldo; S Miyagawa-Tomita; D Kumiski; M L Kirby
Journal:  Dev Biol       Date:  1998-04-15       Impact factor: 3.582

4.  Regulation of cardiac mesodermal and neural crest development by the bHLH transcription factor, dHAND.

Authors:  D Srivastava; T Thomas; Q Lin; M L Kirby; D Brown; E N Olson
Journal:  Nat Genet       Date:  1997-06       Impact factor: 38.330

5.  Altered patterns of cardiac intercellular junction distribution in hypertrophic cardiomyopathy.

Authors:  R Sepp; N J Severs; R G Gourdie
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

6.  Unbalanced t(4;11)(q32;q23) in a 34-year-old man with manifestations of distal monosomy 11q and trisomy 4q syndromes.

Authors:  S A Byatt; E Baker; R I Richards; C Roberts; A Smith
Journal:  Am J Med Genet       Date:  1997-06-27

7.  Heart and extra-embryonic mesodermal defects in mouse embryos lacking the bHLH transcription factor Hand1.

Authors:  A B Firulli; D G McFadden; Q Lin; D Srivastava; E N Olson
Journal:  Nat Genet       Date:  1998-03       Impact factor: 38.330

8.  The Hand1 bHLH transcription factor is essential for placentation and cardiac morphogenesis.

Authors:  P Riley; L Anson-Cartwright; J C Cross
Journal:  Nat Genet       Date:  1998-03       Impact factor: 38.330

9.  A subclass of bHLH proteins required for cardiac morphogenesis.

Authors:  D Srivastava; P Cserjesi; E N Olson
Journal:  Science       Date:  1995-12-22       Impact factor: 47.728

10.  A signaling cascade involving endothelin-1, dHAND and msx1 regulates development of neural-crest-derived branchial arch mesenchyme.

Authors:  T Thomas; H Kurihara; H Yamagishi; Y Kurihara; Y Yazaki; E N Olson; D Srivastava
Journal:  Development       Date:  1998-08       Impact factor: 6.868

View more
  28 in total

Review 1.  Fate choice of post-natal mesoderm progenitors: skeletal versus cardiac muscle plasticity.

Authors:  Domiziana Costamagna; Mattia Quattrocelli; Robin Duelen; Vardine Sahakyan; Ilaria Perini; Giacomo Palazzolo; Maurilio Sampaolesi
Journal:  Cell Mol Life Sci       Date:  2013-08-15       Impact factor: 9.261

Review 2.  MicroRNAs: pleiotropic players in congenital heart disease and regeneration.

Authors:  Sarah C Hoelscher; Stefanie A Doppler; Martina Dreßen; Harald Lahm; Rüdiger Lange; Markus Krane
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

3.  Loss of Hand2 in a population of Periostin lineage cells results in pronounced bradycardia and neonatal death.

Authors:  Nathan J VanDusen; Joshua W Vincentz; Beth A Firulli; Marthe J Howard; Michael Rubart; Anthony B Firulli
Journal:  Dev Biol       Date:  2014-02-22       Impact factor: 3.582

4.  MicroRNA expression, target genes, and signaling pathways in infants with a ventricular septal defect.

Authors:  Hui Chai; Zhaoyuan Yan; Ke Huang; Yuanqing Jiang; Lin Zhang
Journal:  Mol Cell Biochem       Date:  2017-08-18       Impact factor: 3.396

5.  HAND1 loss-of-function within the embryonic myocardium reveals survivable congenital cardiac defects and adult heart failure.

Authors:  Beth A Firulli; Rajani M George; Jade Harkin; Kevin P Toolan; Hongyu Gao; Yunlong Liu; Wenjun Zhang; Loren J Field; Ying Liu; Weinian Shou; Ronald Mark Payne; Michael Rubart-von der Lohe; Anthony B Firulli
Journal:  Cardiovasc Res       Date:  2020-03-01       Impact factor: 10.787

6.  MESP1 Mutations in Patients with Congenital Heart Defects.

Authors:  Petra Werner; Brande Latney; Matthew A Deardorff; Elizabeth Goldmuntz
Journal:  Hum Mutat       Date:  2016-01-19       Impact factor: 4.878

7.  HAND2 targets define a network of transcriptional regulators that compartmentalize the early limb bud mesenchyme.

Authors:  Marco Osterwalder; Dario Speziale; Malak Shoukry; Rajiv Mohan; Robert Ivanek; Manuel Kohler; Christian Beisel; Xiaohui Wen; Suzie J Scales; Vincent M Christoffels; Axel Visel; Javier Lopez-Rios; Rolf Zeller
Journal:  Dev Cell       Date:  2014-11-10       Impact factor: 12.270

Review 8.  Transcriptional networks regulating the costamere, sarcomere, and other cytoskeletal structures in striated muscle.

Authors:  Nelsa L Estrella; Francisco J Naya
Journal:  Cell Mol Life Sci       Date:  2013-11-12       Impact factor: 9.261

9.  HAND1 Loss-of-Function Mutation Causes Tetralogy of Fallot.

Authors:  Juan Wang; Xiao-Qing Hu; Yu-Han Guo; Jian-Yun Gu; Jia-Hong Xu; Yan-Jie Li; Ning Li; Xiao-Xiao Yang; Yi-Qing Yang
Journal:  Pediatr Cardiol       Date:  2016-12-10       Impact factor: 1.655

10.  Effect of human donor cell source on differentiation and function of cardiac induced pluripotent stem cells.

Authors:  Veronica Sanchez-Freire; Andrew S Lee; Shijun Hu; Oscar J Abilez; Ping Liang; Feng Lan; Bruno C Huber; Sang-Ging Ong; Wan Xing Hong; Mei Huang; Joseph C Wu
Journal:  J Am Coll Cardiol       Date:  2014-08-05       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.